Soluble Epoxide Hydrolase Inhibitor, NCND - CAS 402939-18-8 - Calbiochem manufacturers
|
| | Soluble Epoxide Hydrolase Inhibitor, NCND - CAS 402939-18-8 - Calbiochem Basic information |
| Product Name: | Soluble Epoxide Hydrolase Inhibitor, NCND - CAS 402939-18-8 - Calbiochem | | Synonyms: | Soluble Epoxide Hydrolase Inhibitor, NCND - CAS 402939-18-8 - Calbiochem;N-Cyclohexyl-N?-dodecylurea, 1-Cyclohexyl-3?-dodecylurea, CDU;pressure,1 Cyclohexyl 3 dodecyl urea,epoxyeicosatrienoic,inhibit,Inhibitor,acid,1Cyclohexyl3dodecyl urea,antihypertensive,Epoxide Hydrolase,EET,blood;Urea, N-cyclohexyl-N'-dodecyl-;N-CYCLOHEXYL-N'-DODECYLUREA | | CAS: | 402939-18-8 | | MF: | C19H38N2O | | MW: | 310.52 | | EINECS: | | | Product Categories: | | | Mol File: | 402939-18-8.mol |  |
| | Soluble Epoxide Hydrolase Inhibitor, NCND - CAS 402939-18-8 - Calbiochem Chemical Properties |
| Boiling point | 465.1±12.0 °C(Predicted) | | density | 0.92±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Ethanol: 16.67 mg/mL (53.68 mM) | | form | Solid | | pka | 14.29±0.20(Predicted) | | color | White to off-white |
| | Soluble Epoxide Hydrolase Inhibitor, NCND - CAS 402939-18-8 - Calbiochem Usage And Synthesis |
| Uses | 1-Cyclohexyl-3-dodecyl urea (CDU; N-Cyclohexyl-N-dodecyl urea; NCND) is a highly selective soluble epoxide hydrolase (sEH) inhibitor. 1-Cyclohexyl-3-dodecyl urea (CDU; N-Cyclohexyl-N-dodecyl urea; NCND) increases epoxyeicosatrienoic acids (EETs) levels and lowers blood pressure in angiotensin II (Ang II) hypertension[1]. | | Biological Activity | Cell permeable: yes', 'Primary Target Soluble epoxide hydrolase', 'Product competes with ATP.', 'Reversible: no', 'Target IC50: 9.8 nM for mouse recombinant sEH, 85.2 nM for human recombinant sEH | | in vivo | 1-Cyclohexyl-3-dodecyl urea (CDU; N-Cyclohexyl-N-dodecyl urea; NCND) (intraperitoneal injection; 3mg/day; 4 days) lowers systolic blood pressure by 30 mm Hg in Ang II hypertensive animals, whereas the corn oil vehicle has no effect on blood pressure in normotensive or Ang II hypertensive animals[1]. | Animal Model: | Male Sprague-Dawley rats[1] | | Dosage: | 3mg/day | | Administration: | Intraperitoneal injection; 4 days | | Result: | Had antihypertensive properties. |
| | References | [1] Imig JD,et al. Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension.Hypertension. 2002 Feb;39(2 Pt 2):690-4. DOI:10.1161/hy0202.103788 |
| | Soluble Epoxide Hydrolase Inhibitor, NCND - CAS 402939-18-8 - Calbiochem Preparation Products And Raw materials |
|